H. Alnajashi, “Ocrelizumab and Rituximab for the Treatment of Multiple Sclerosis Patients: A Real-World Clinical Experience: Comparing Ocrelizumab and Rituximab in MS Treatment”, J. Contemp. Med. Sci., vol. 11, no. 4, Aug. 2025.